By Jeffrey May, J.D.
The FTC and FDA have sent warning letters to companies that are purportedly marketing supplements as cures for Alzheimer’s disease and dementia.
Today, the FTC announced that, together with the U.S. Food and Drug Administration, it has notified three companies that they may be making false or unsubstantiated health claims in violation of the FTC Act for their supplements sold online. The letters were sent after the FDA conducted a review of the companies’ websites. In addition to the three letters jointly issued with the FTC, the FDA posted 12 warning letters and five online advisory letters, informing recipients that they are marketing unapproved new drugs and/or misbranded drugs that claim to prevent, treat, or cure Alzheimer’s disease and a number of other serious diseases and health conditions and that these products have been sold in violation of the Federal Food, Drug, and Cosmetic Act.
The joint FTC/FDA letters were sent to Gold Crown Natural Products, TEK Naturals, and Pure Nootropics. These companies were instructed to contact the FTC within 15 days regarding actions taken to address the agency’s concerns. The FTC can bring civil enforcement actions against companies deceptively promoting, marketing, or selling health-related products and seek monetary redress for consumers, according to today's FTC announcement.
In the letters, the government explained that it is unlawful under the FTC Act to advertise that a product can prevent, treat, or cure human disease without competent and reliable scientific evidence. The FTC expressed concern that the efficacy claims made by the firms were not properly substantiated.
Companies: Gold Crown Natural Products; Pure Nootropics, LLC; TEK Naturals
MainStory: TopStory Advertising ConsumerProtection FederalTradeCommissionNews
Interested in submitting an article?
Submit your information to us today!Learn More
Antitrust Law Daily: Breaking legal news at your fingertips
Sign up today for your free trial to this daily reporting service created by attorneys, for attorneys. Stay up to date on antitrust legal matters with same-day coverage of breaking news, court decisions, legislation, and regulatory activity with easy access through email or mobile app.